妊娠期卵巢肿瘤诊治专家共识(2020)

2020-05-15 中国优生科学协会 中国实用妇科与产科杂志.2020,36(5):432-440.

卵巢肿瘤是常见的女性生殖系统肿瘤,可发生在包括育龄期的任何年龄段女性。随着女性生育年龄延后、辅助生殖技术的广泛应用,妊娠合并卵巢肿瘤的发生率逐渐增加。关于非妊娠期卵巢肿瘤的诊治,国内外均有不少指南、规

中文标题:

妊娠期卵巢肿瘤诊治专家共识(2020)

发布机构:

中国优生科学协会

发布日期:

2020-05-15

简要介绍:

卵巢肿瘤是常见的女性生殖系统肿瘤,可发生在包括育龄期的任何年龄段女性。随着女性生育年龄延后、辅助生殖技术的广泛应用,妊娠合并卵巢肿瘤的发生率逐渐增加。关于非妊娠期卵巢肿瘤的诊治,国内外均有不少指南、规范和共识;而妊娠期卵巢肿瘤与非孕期不同,需要考虑到妊娠与肿瘤的相互影响,亟需一个规范化、人性化、个体化的专家共识。有鉴于此,中国优生科学协会肿瘤生殖学分会及中国医师协会微无创医学专业委员会妇科肿瘤专委会组织有关专家制订本共识,以期为妊娠合并卵巢肿瘤的规范化治疗提供有益的借鉴。

相关资料下载:
[AttachmentFileName(sort=1, fileName=妊娠期卵巢肿瘤诊治专家共识_2020_王玉东.pdf)] GetToolGuiderByIdResponse(projectId=1, id=9779f1c00190906e, title=妊娠期卵巢肿瘤诊治专家共识(2020), enTitle=, guiderFrom=中国实用妇科与产科杂志.2020,36(5):432-440., authorId=0, author=, summary=卵巢肿瘤是常见的女性生殖系统肿瘤,可发生在包括育龄期的任何年龄段女性。随着女性生育年龄延后、辅助生殖技术的广泛应用,妊娠合并卵巢肿瘤的发生率逐渐增加。关于非妊娠期卵巢肿瘤的诊治,国内外均有不少指南、规, cover=https://img.medsci.cn/2020525/1590341488064_2020535.jpg, journalId=0, articlesId=null, associationId=1806, associationName=中国优生科学协会, associationIntro=, copyright=0, guiderPublishedTime=Fri May 15 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>卵巢肿瘤是常见的女性生殖系统肿瘤,可发生在包括育龄期的任何年龄段女性。随着女性生育年龄延后、辅助生殖技术的广泛应用,妊娠合并卵巢肿瘤的发生率逐渐增加。关于非妊娠期卵巢肿瘤的诊治,国内外均有不少指南、规范和共识;而妊娠期卵巢肿瘤与非孕期不同,需要考虑到妊娠与肿瘤的相互影响,亟需一个规范化、人性化、个体化的专家共识。有鉴于此,中国优生科学协会肿瘤生殖学分会及中国医师协会微无创医学专业委员会妇科肿瘤专委会组织有关专家制订本共识,以期为妊娠合并卵巢肿瘤的规范化治疗提供有益的借鉴。</p> </div> </div> </div>, tagList=[TagDto(tagId=17475, tagName=卵巢肿瘤)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=17475, guiderKeyword=卵巢肿瘤, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4548, appHits=402, showAppHits=250, pcHits=1397, showPcHits=4344, likes=5, shares=28, comments=7, approvalStatus=1, publishedTime=Mon May 25 01:44:51 CST 2020, publishedTimeString=2020-05-15, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Mon May 25 01:31:42 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Wed Jan 03 00:36:16 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=妊娠期卵巢肿瘤诊治专家共识_2020_王玉东.pdf)])
妊娠期卵巢肿瘤诊治专家共识_2020_王玉东.pdf
下载请点击:
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1084622, encodeId=195310846226a, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb9b2033720, createdName=1331e8257am, createdTime=Mon Dec 27 10:44:43 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070080, encodeId=6e1910e0080b2, content=谢谢,值得学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=陌上咖啡, createdTime=Sun Nov 14 10:02:15 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997259, encodeId=592899e2593f, content=文章不错,值得一看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33fb5543777, createdName=唐乃富, createdTime=Wed Jul 07 17:35:30 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954511, encodeId=000a954511de, content=受益匪浅!好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Apr 07 13:12:49 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888720, encodeId=14df888e2039, content=有用,帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b72b5126564, createdName=姓許名書, createdTime=Sun Sep 27 13:51:46 CST 2020, time=2020-09-27, status=1, ipAttribution=)]
    2021-12-27 1331e8257am

    非常实用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1084622, encodeId=195310846226a, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb9b2033720, createdName=1331e8257am, createdTime=Mon Dec 27 10:44:43 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070080, encodeId=6e1910e0080b2, content=谢谢,值得学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=陌上咖啡, createdTime=Sun Nov 14 10:02:15 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997259, encodeId=592899e2593f, content=文章不错,值得一看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33fb5543777, createdName=唐乃富, createdTime=Wed Jul 07 17:35:30 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954511, encodeId=000a954511de, content=受益匪浅!好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Apr 07 13:12:49 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888720, encodeId=14df888e2039, content=有用,帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b72b5126564, createdName=姓許名書, createdTime=Sun Sep 27 13:51:46 CST 2020, time=2020-09-27, status=1, ipAttribution=)]
    2021-11-14 陌上咖啡

    谢谢,值得学习!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1084622, encodeId=195310846226a, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb9b2033720, createdName=1331e8257am, createdTime=Mon Dec 27 10:44:43 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070080, encodeId=6e1910e0080b2, content=谢谢,值得学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=陌上咖啡, createdTime=Sun Nov 14 10:02:15 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997259, encodeId=592899e2593f, content=文章不错,值得一看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33fb5543777, createdName=唐乃富, createdTime=Wed Jul 07 17:35:30 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954511, encodeId=000a954511de, content=受益匪浅!好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Apr 07 13:12:49 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888720, encodeId=14df888e2039, content=有用,帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b72b5126564, createdName=姓許名書, createdTime=Sun Sep 27 13:51:46 CST 2020, time=2020-09-27, status=1, ipAttribution=)]
    2021-07-07 唐乃富

    文章不错,值得一看

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1084622, encodeId=195310846226a, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb9b2033720, createdName=1331e8257am, createdTime=Mon Dec 27 10:44:43 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070080, encodeId=6e1910e0080b2, content=谢谢,值得学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=陌上咖啡, createdTime=Sun Nov 14 10:02:15 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997259, encodeId=592899e2593f, content=文章不错,值得一看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33fb5543777, createdName=唐乃富, createdTime=Wed Jul 07 17:35:30 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954511, encodeId=000a954511de, content=受益匪浅!好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Apr 07 13:12:49 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888720, encodeId=14df888e2039, content=有用,帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b72b5126564, createdName=姓許名書, createdTime=Sun Sep 27 13:51:46 CST 2020, time=2020-09-27, status=1, ipAttribution=)]
    2021-04-07 湘雅科教

    受益匪浅!好文章。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1084622, encodeId=195310846226a, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb9b2033720, createdName=1331e8257am, createdTime=Mon Dec 27 10:44:43 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070080, encodeId=6e1910e0080b2, content=谢谢,值得学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=陌上咖啡, createdTime=Sun Nov 14 10:02:15 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997259, encodeId=592899e2593f, content=文章不错,值得一看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33fb5543777, createdName=唐乃富, createdTime=Wed Jul 07 17:35:30 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954511, encodeId=000a954511de, content=受益匪浅!好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Apr 07 13:12:49 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888720, encodeId=14df888e2039, content=有用,帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b72b5126564, createdName=姓許名書, createdTime=Sun Sep 27 13:51:46 CST 2020, time=2020-09-27, status=1, ipAttribution=)]
    2020-09-27 姓許名書

    有用,帮助

    0

拓展阅读

2020 CNGOF指南:交界性卵巢肿瘤-第1部分:流行病学,生物病理学,影像学和生物标志物

法国国家妇产科医生协会(CNGOF,coll&egrave;ge national des gyn&eacute;cologues et obst&eacute;triciens francais) · 2020-11-04

2020 CNGOF指南:交界性卵巢肿瘤-第2部分:手术治疗,随访,激素替代治疗,生育管理以及保留生育力

法国国家妇产科医生协会(CNGOF,coll&egrave;ge national des gyn&eacute;cologues et obst&eacute;triciens francais) · 2020-11-04

2021 ESGO/ISUOG/IOTA/ESGE共识声明:卵巢肿瘤的术前诊断

欧洲妇科肿瘤学会(ESGO,European Society of Gynecological Oncology) · 2021-06-10

卵巢肿瘤ADNEX MR评分系统的应用解读及研究进展

南通大学附属南通市妇幼保健院影像科 · 2023-06-20

卵巢肿瘤良恶性风险评估方法学中国专家共识(2024年版)

中国医师协会微无创医学专业委员会 · 2024-03-02